Children's Hospital of Wisconsin logo   spacing image
About Children's Hospital and Health Systemspacing image
Quick Links for:
spacing imageHealth Care Professionalsspacing image
    Search:
                          
Horizontal stripes
spacing imageHealth InformationPrograms & ClinicsFind a DoctorMaps & DirectionsGiving & VolunteeringNews & CalendarResearchAdvocacy & CommunityQualityCareersspacing image
Children's Research Institute Logo
spacing image
  Overview
 
  Human Research Review Board
 
 
Side navigation, highlighted area, top left Side navigation, highlighted area, top center Side navigation, highlighted area, top right
  Find an investigator or research program
spacing image spacing image
spacing image Find an investigator: Division
spacing image spacing image
spacing image Find an investigator: Interest
spacing image spacing image
spacing image Find an investigator: Theme
spacing image spacing image
spacing image Find an investigator: Name
 
Side navigation, highlighted area, bottom left Side navigation, highlighted area, bottom center Side navigation, highlighted area, bottom right
 
  Leadership
 
  Translational research programs
 
  News and events
 
  Current research at CRI
 
  Support CRI
 
  Contact us
 
spacing image
spacing image spacing image E-mail this page E-mail this page     Print this page Print this page
spacing image spacing image

Beth A. Drolet, MD 

Titles
Medical director, Dermatology, Birthmarks and Vascular Anomalies Center, Children's Hospital of Wisconsin; professor, Dermatology and Pediatrics; chief, Pediatric Dermatology, Medical College of Wisconsin.

Division
Dermatology

Research interests
Birthmarks and vascular anomalies, dermatologic diseases

Study interests
Hemangiomas of infancy, large facial hemangiomas, associated vascular anomalies.

Education
Medical degree, Loyola University, Chicago, 1991; internship, Medicine, University of Colorado, Denver, 1992; residency, Dermatology, Medical College of Wisconsin, Milwaukee, 1995; fellowship, Clinical Research and Pediatric Dermatology, Medical College of Wisconsin, Milwaukee, 1996.

Certifications
American Board of Dermatology, Pediatric Dermatology.

Honors
Loyola University Student Research Fellowship; Alpha Omega Alpha; Best Doctors in Milwaukee (Milwaukee Magazine) 2004, 2006, 2007; American Skin Association Research Award, 2004; Patient Directed Investigation Award, Dermatology Foundation, 2004; Society for Pediatric Dermatology Research Award, 2006; Small Business Times Health Care Hero Award, 2006.

Representative publications

  • Haggstrom AN, Drolet BA, Baselga E, Chamlin S, Esterly NB, Garzon J, Horii K, Lucky A, Metry DW, Mancini AJ, Nopper A, Frieden IJ. Prospective Study of Infantile Hemangiomas, Part 1: Demographic, Prenatal and Perinatal Characteristics. Journal of Pediatrics. 2007; 150:291-294.
  • Maronn M, Corden T, Drolet BA. Pnuemocytosis Carinii Pneumonia in Infant Treated with Oral Steroids for Hemangioma. Archives of Dermatology. 2007; 143:1224-1225.
  • Chamlin SL, Haggstrom AN, Drolet BA, Baselga E, Frieden IJ, Garzon MC, Horii KA, Lucky AW, Metry DW, Newell B, Mancini AJ. Ulcerated Hemangiomas of Infancy: Who, What, Where and When? Journal of Pediatrics. 2007; 151:684-689.
  • Metry DW, Siegel D, Cordisco MR, Pope E, Prendiville J, Drolet BA, Horii K, Liang M, Stein S, Frieden IJ. A Comparison of Disease Severity Among Affected Males. Archives of Dermatology. Epub ahead of print 2007.
  • Drolet BA, Frieden IJ. Infantile Hemangiomas: An Emerging Health Issue Linked to an Increasing Rate of Low Birth Weight Infants in the United States. Journal of Pediatrics (submitted).

Grants

  • Phase II Clinical Trial Assessing Efficacy and Safety of Oral Prednisolone vs. Vincristine in the Treatment of Infantile Hemangiomas, Food and Drug Administration OPD Grant Program, 1/08-1/11, co-principal investigator.
  • Immune Suppression of Infants Treated with Oral Corticosteroids for Infantile Hemangiomas, Society for Pediatric Dermatology, 11/15/06-11/14/08, principal investigator.
  • Immune Suppression of Infants Treated with Oral Corticosteroids for Infantile Hemangiomas, Research Affairs Committee, Medical College of Wisconsin, 11/1/07-6/30/08, principal investigator.
  • Large Facial Hemangiomas and Associated Vascular Anomalies, Children's Research Institute, 2/15/05-13/31/07, principal investigator.
  • Multifocal Lymphangioendotheliomatosis with Thrombocytopenia, Children's Research Institute, principal investigator.
  • Prospective Cohort Study of Hemangiomas of Infancy, Spirit Foundation 10/03-12/08, principal investigator.
  • Phase II Clinical Trial Assessing Efficacy and Safety of Oral Prednisolone vs. Vincristine in the Treatment of Infantile Hemangiomas, Greater Milwaukee Foundation, 6/07-6/10, co-principal investigator.
  • Genomewide Association Study on Infantile Hemangiomas, Bleser Family Foundation (through Children's Hospital of Wisconsin Foundation), 12/06-12/09, principal investigator.
  • Phase II Clinical Trial Assessing Efficacy and Safety of Oral Prednisolone vs. Vincristine in the Treatment of Infantile Hemangiomas, Bleser Family Foundation (through Children's Hospital of Wisconsin Foundation), 12/07-12/10, co-principal investigator.

Contact
Children's Research Institute
8701 Watertown Plank Road
Wauwatosa, WI 53226
Phone: (414) 266-1569
Fax: (414) 266-4778
E-mail: drolet@mcw.edu

 

spacing image Arrow Back to top
spacing image page footer spacing image
spacing image
spacing image